Predicting survival in NSCLC patients with poor performance status in resource-constrained settings

Targeted therapy for breast cancer

Oncogenesis: Lung cancer

Triple negative breast cancer: OlympiA study

Pancreatic and Hepatobiliary Cancers

Immunotherapy in lung cancer

Oesophageal and gastric cancers

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment

Part 1: When to test

Part 4: Metastatic prostate cancer and HRR defects

Part 5: BRCA 1/2 mutations and prostate cancer

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer